Immuron Files Pre-Investigational New Drug Application With FDA for IMM-529

Biopharmaceutical company Immuron (ASX:IMC) filed a pre-investigational new drug application with the US Food and Drug Administration for IMM-529, a candidate for the treatment of gastrointestinal dis

MT NewswiresJul 1 20:27 ET

Immuron Says Jeannie Joughin Was Appointed to Board >IMRN

Immuron Says Jeannie Joughin Was Appointed to Board >IMRN

Dow JonesMay 31 06:02 ET

Immuron Says Roger Aston Has Resigned From Board of Directors

Immuron Says Roger Aston Has Resigned From Board of Directors

Dow JonesMay 31 06:01 ET

Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%

Immuron (ASX:IMC) saw a 51% surge in global sales in the March quarter compared with the prior comparative period, driven by a strong performance of its Travelan product in Australia, according to a W

MT NewswiresApr 9 21:46 ET

ADRs Close Lower, Immuron Ltd. Declines 17.1%

This article was automatically generated by Dow Jones Newswires using technology from Automated Insights. International stocks trading in New York closed lower on Monday, as the S&P/BNY Mellon index

Dow JonesMar 11 16:50 ET

We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate

Yahoo FinanceMar 8 15:47 ET